To confirm the clinical relevance of FoxM1/ADAM17 axis in GBM, we examined the protein levels of FoxM1, ADAM17 and mesenchymal markers in human primary GBM samples by tissue microarray (Fig. 6a). This evidence concerns the gene FOXM1 and glioblastoma.